IL6 and systemic lupus erythematosus: The SLE is caused by immune complexes depositing on organs and extensive injury were caused.7 The patients with SLE are characterized by BCR-initiated signaling and IL-6 production, including alter in B cell subset distribution.8 Therefore, the main clinical strategy for treating SLE was blocking the immune cells stimulating cytokine that affects the development of SLE.